- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03635944
Nutritional Care and Head Growth in Preterm Infants (KARLY)
Nutritional Care Influences Head Growth at Discharge in Extremely Low Birth Weight Infants.
As extremely low birth weight infants are high-risk patients, the study aimed to compare neonatal care, nutritional strategy and postnatal growth of these infants in two European neonatal units. A retrospective study included extremely low birth weight infants born in Lyon, France or in Stockholm, Sweden. Data on morbidity, treatments, care practices, macro-nutrient intakes and postnatal growth were collected to determine risk factors of extra uterine growth restriction at discharge.
By comparing postnatal growth in ELBW infants hospitalized in two European neonatal intensive care units with different nutritional and extra nutritional care,our objective was to evaluate the role of nutrition in this population of preterm infants.
Study Overview
Status
Conditions
Detailed Description
In a retrospective study, all ELBW infants (birth weight under 1000 g) with a gestational age between 23 and 28 weeks were included if they were admitted during the first 24 hours of life and stayed for at least seven weeks in two European units (Lyon, france, and Stockholm, Sweden). Parenteral and enteral nutrition policies were detailed and protein and energy intakes were collected.Growth assessment Postnatal growth was precisely evaluated and compared in the two groups of infants.
Body weight, crown-heel length and head circumference were measured in both units at birth and until discharge. We calculated z-scores and changes in z-scores between birth and 36 weeks post-conceptional age (delta z-score) for body weight, HC, and crown-to-heel length using Olsen's references. Intra-uterine growth restriction was defined as a birth weight below or equal to minus two standard deviations. Extra-uterine growth restriction was defined as a z-score loss above or equal one standard deviation between birth and 36 weeks PCA. I
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69004
- Hopital de la croix rousse
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- birth weight under 1000 grams
- gestational age (GA) between 23 and 28 weeks
- born in 2012
- admitted during the first 24 hours of life
- stayed in one of the two studied units for at least 7 weeks before transfer to the referring hospital, discharge to home or death.
Exclusion Criteria:
- Neonates with congenital anomalies
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group A
Infants born in Lyon (France)
|
|
Group B
Infants born in Stockholm (Sweden)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight gain during hospitalization
Time Frame: between birth and 40 weeks
|
difference in weight between birth and discharge
|
between birth and 40 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Crown-heel length gain during hospitalization
Time Frame: between birth and 40 weeks
|
difference in recumbent length between birth and discharge
|
between birth and 40 weeks
|
|
Head circumference gain during hospitalization
Time Frame: between birth and 40 weeks
|
difference in head circumference between birth and discharge
|
between birth and 40 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PICAUD JC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth Retardation
-
University of California, DavisCompletedGrowth Acceleration | Growth RetardationUnited States
-
Central Hospital, Nancy, FranceCompletedGrowth Retardation
-
Tanzania Food and Drugs AuthorityUniversity Ghent; International Foundation for Science (IFS); The Nelson Mandela... and other collaboratorsCompleted
-
University GhentInstitut de Recherche en Sciences de la Sante, Burkina Faso; NutrisetCompletedGrowth Retardation | Infant MorbidityBurkina Faso
-
GeneScience Pharmaceuticals Co., Ltd.Unknown
-
Nantes University HospitalTerminatedIntra Uterine Growth RetardationFrance
-
amera mohamedUnknownThe Relationship Between Second Trimester Placental Growth Factor Level and Fetal Growth RestrictionIntra Uterine Growth RetardationEgypt
-
Poitiers University HospitalCompletedIntrauterine Growth Retardation (IUGR)France
-
PfizerCompletedGrowth Disorders | Intrauterine Growth RetardationFrance
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedChildren Born With Serious Intra-uterine Growth Retardation